Amphiphilic cyclodextrin nanoparticles

Aktas, 2015, Amphiphilic cyclodextrins as enabling excipients for drug delivery and for decades of scientific collaboration: tribute to a distinguished scientist, French representative and friend – a historical perspective, J. Drug Deliv. Sci. Technol., 30, 261, 10.1016/j.jddst.2015.07.019 Aranda, 2013, Targeted gene delivery by new folate-polycationic amphiphilic cyclodextrin-DNA nanocomplexes in vitro and in vivo, Eur. J. Pharm. Biopharm., 85, 390, 10.1016/j.ejpb.2013.06.011 Bellanger, 1992, NMR investigations of the conformation of new cyclodextrins-based amphiphilic transporters for hydrophobic drugs: molecular lollipops, J. Mol. Struct., 15, 215, 10.1016/0022-2860(92)87087-C Bilensoy, 2009, Recent advances and future directions in amphiphilic cyclodextrin nanoparticles, Expert Opin. Drug Deliv., 6, 1161, 10.1517/17425240903222218 Bilensoy, 2008, Safety and efficacy of amphiphilic ß-cyclodextrin nanoparticles for paclitaxel delivery, Int. J. Pharm., 347, 163170, 10.1016/j.ijpharm.2007.06.051 Bilensoy, 2015, Amphiphilic cyclodextrin nanoparticles for effective and safe delivery of anticancer drugs, Adv. Exp. Med. Biol., 822, 201, 10.1007/978-3-319-08927-0_24 Bonnet, 2015, Cyclodextrin nanoassemblies: a promising tool for drug delivery, Drug Discovery Today, 20, 1120, 10.1016/j.drudis.2015.05.008 Brewster, 2007, Cyclodextrins as pharmaceutical solubilizers, Adv. Drug Deliv. Rev., 59, 645, 10.1016/j.addr.2007.05.012 Carrier, 2007, The utility of cyclodextrins for enhancing oral bioavailability, J. Controlled Release, 123, 78, 10.1016/j.jconrel.2007.07.018 Challa, 2005, Cyclodextrins in drug delivery: an updated review, AAPS PharmSciTech, 6, E329, 10.1208/pt060243 Cheng, 2007, Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery, Biomaterials, 28, 869, 10.1016/j.biomaterials.2006.09.047 Cirpanli, 2011, Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model, Int. J. Pharm., 403, 201, 10.1016/j.ijpharm.2010.10.015 Coleman, 1992, Aggregation of cyclodextrins – an explanation of the abnormal solubility of beta-cyclodextrin, J. Inclus. Phenom. Mol., 13, 139, 10.1007/BF01053637 Concheiro, 2013, Chemically cross-linked and grafted cyclodextrin hydrogels: from nanostructures to drug-eluting medical devices, Adv. Drug Deliv. Rev., 65, 1188, 10.1016/j.addr.2013.04.015 Danhier, 2010, To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery, J. Controlled Release, 148, 135, 10.1016/j.jconrel.2010.08.027 Dass, 2000, Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. A review, J. Pharm. Pharmacol., 52, 731, 10.1211/0022357001774606 Davis, 2009, The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic, Mol. Pharm., 6, 659, 10.1021/mp900015y Del Valle, 2004, Cyclodextrins and their uses: a review, Process Biochem., 39, 1033, 10.1016/S0032-9592(03)00258-9 Diaz-Moscoso, 2010, Insights in cellular uptake mechanisms of pDNA-polycationic amphiphilic cyclodextrin nanoparticles (CDplexes), J. Control. Release, 143, 318, 10.1016/j.jconrel.2010.01.016 Donohue, 2002, Cationic beta-cyclodextrin bilayer vesicles, Chem. Commun. (Camb), 2864, 10.1039/B207238F Dubes, 2001, An efficient regio-specific synthetic route to multiply substituted acyl-sulphated beta-cyclodextrins, Tetrahedron Lett., 42, 9147, 10.1016/S0040-4039(01)01992-X Dubes, 2003, Synthesis and characterisation of sulfated amphiphilic alpha-, beta- and gamma-cyclodextrins: application to the complexation of acyclovir, Carbohyd. Res., 338, 2185, 10.1016/S0008-6215(03)00356-2 Dubes, 2003, Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins, Eur. J. Pharm. Biopharm., 55, 279, 10.1016/S0939-6411(03)00020-1 Duchene, 2016, Thirty years with cyclodextrins, Int. J. Pharm., 514, 58, 10.1016/j.ijpharm.2016.07.030 Duchene, 1999, Cyclodextrins in targeting:Application to nanoparticles, Adv. Drug Deliv. Rev., 36, 29, 10.1016/S0169-409X(98)00053-2 Duchene, 1999, Cyclodextrins and carrier systems, J. Control. Release, 62, 263, 10.1016/S0168-3659(99)00046-2 Duchene, 2005, New uses of cyclodextrins, Eur. J. Pharm. Sci., 25, S1 Duncan, 2003, The dawning era of polymer therapeutics, Nat. Rev. Drug Discov., 2, 347, 10.1038/nrd1088 Erdogar, 2016, Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles, Int. J. Pharm., 509, 375, 10.1016/j.ijpharm.2016.05.040 Erdogar, 2016, Amphiphilic cyclodextrin derivatives for targeted drug delivery to tumors, Curr. Top. Med. Chem. Evans, 2016, Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo, Nanomed.: Nanotechnol. Biol. Med., 12, 2341, 10.1016/j.nano.2016.06.014 Evans, 2017, Formulation and evaluation of anisamide-Targeted amphiphilic cyclodextrin nanoparticles to promote therapeutic gene silencing in a 3D prostate cancer bone metastases model, Mol. Pharmaceutics, 14, 42, 10.1021/acs.molpharmaceut.6b00646 Fessi, 1989, Nanocapsule formation by interfacial polymer deposition following solvent displacement, Int. J. Pharm., 55, R1, 10.1016/0378-5173(89)90281-0 Ganachaud, 2005, Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulsification as an alternative to ultrasonic and high-shear devices, Chemphyschem, 6, 209, 10.1002/cphc.200400527 Ghera, 2009, Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir, Int. J. Pharm., 375, 155, 10.1016/j.ijpharm.2009.04.004 Godinho, 2014, PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability, Int. J. Pharm., 473, 105, 10.1016/j.ijpharm.2014.06.054 Gooding, 2015, Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis, Eur. J. Pharm. Sci., 71, 80, 10.1016/j.ejps.2015.02.007 Haley, 2008, Nanoparticles for drug delivery in cancer treatment, Urol. Oncol., 26, 57, 10.1016/j.urolonc.2007.03.015 Hirayama, 1999, Cyclodextrin-based controlled drug release system, Adv. Drug Deliv. Rev., 36, 125, 10.1016/S0169-409X(98)00058-1 Irie, 1997, Pharmaceutical applications of cyclodextrins. III:Toxicological issues and safety evaluation, J. Pharm. Sci., 86, 147, 10.1021/js960213f Irie, 1999, Cyclodextrins in peptide and protein delivery, Adv. Drug Deliv. Rev., 36, 101, 10.1016/S0169-409X(98)00057-X Jia, 2016, Unimolecular micelles of amphiphilic cyclodextrin-Core star-Like copolymers with covalent pH-responsive linkage of anticancer prodrugs, Mol. Pharm. Kauscher, 2013, Incorporation of amphiphilic cyclodextrins into liposomes as artificial receptor units, Langmuir, 29, 7377, 10.1021/la3045434 Kell, 2014, How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion, Front. Pharmacol., 5, 231, 10.3389/fphar.2014.00231 Khajeh, 2014, The influence of cholesterol on interactions and dynamics of ibuprofen in a lipid bilayer, Biochim. Biophys. Acta, 1838, 2431, 10.1016/j.bbamem.2014.05.029 Kraus, 2001, General approach to the synthesis of persubstituted hydrophilic and amphiphilic beta-cyclodextrin derivatives, J. Org. Chem., 66, 4595, 10.1021/jo010046q Kurkov, 2013, Cyclodextrins, Int. J. Pharm., 453, 167, 10.1016/j.ijpharm.2012.06.055 Kusakabe, 2016, Intranasal hydroxypropyl-beta-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection, Vaccine, 34, 3191, 10.1016/j.vaccine.2016.04.001 Lakkakula, 2014, A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications, Nanomedicine (Lond), 9, 877, 10.2217/nnm.14.41 Lemos-Senna, 1998, Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method. Influence of the surfactant on preparation and hydrophobic drug loading, Int. J. Pharm., 170, 119, 10.1016/S0378-5173(98)00147-1 Li, 1992, Cyclodextrins and their applications in analytical-chemistry, Chem. Rev., 92, 1457, 10.1021/cr00014a009 Loftsson, 1996, Pharmaceutical applications of cyclodextrins. 1:Drug solubilization and stabilization, J. Pharm. Sci., 85, 1017, 10.1021/js950534b Loftsson, 2011, Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes, J. Pharm. Pharmacol., 63, 1119, 10.1111/j.2042-7158.2011.01279.x Loftsson, 2007, Cyclodextrins and their pharmaceutical applications, Int. J. Pharm., 329, 1, 10.1016/j.ijpharm.2006.10.044 Loftsson, 2004, The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs, J. Drug Deliv. Sci. Technol., 14, 35, 10.1016/S1773-2247(04)50003-5 Lysik, 2003, Innovations in oligonucleotide drug delivery, J. Pharm. Sci., 92, 1559, 10.1002/jps.10399 Mainardes, 2005, PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution, Int. J. Pharm., 290, 144 Memisoglu, 2002, Amphiphilic beta-cyclodextrins modified on the primary face: synthesis, characterization, and evaluation of their potential as novel excipients in the preparation of nanocapsules, J. Pharm. Sci., 91, 1214, 10.1002/jps.10105 Memisoglu, 2003, Direct formation of nanospheres from amphiphilic beta-cyclodextrin inclusion complexes, Pharm. Res., 20, 117, 10.1023/A:1022263111961 Memisoglu-Bilensoy, 2005, Tarnoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity, J. Control. Release, 104, 489, 10.1016/j.jconrel.2005.03.006 Mendez-Ardoy, 2011, Polycationic amphiphilic cyclodextrin-based nanoparticles for therapeutic gene delivery, Nanomedicine (Lond), 6, 1697, 10.2217/nnm.11.59 Messner, 2010, Self-assembled cyclodextrin aggregates and nanoparticles, Int. J. Pharm., 387, 199, 10.1016/j.ijpharm.2009.11.035 Miyazawa, 1995, Physicochemical properties and inclusion complex-formation of delta-cyclodextrin, Eur. J. Pharm. Sci., 3, 153, 10.1016/0928-0987(95)00006-Y Mohammad, 2014, Cholesterol depletion by methyl-beta-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma, Mol. Cancer, 13, 204, 10.1186/1476-4598-13-204 Mu, 2014, Chemical basis of interactions between engineered nanoparticles and biological systems, Chem. Rev., 114, 7740, 10.1021/cr400295a O’Mahony, 2013, Cationic and PEGylated amphiphilic cyclodextrins: Co-formulation opportunities for neuronal sirna delivery, PLoS One, 8, e66413, 10.1371/journal.pone.0066413 Onishi, 2015, Hydroxypropyl-beta-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen, J. Immunol., 194, 2673, 10.4049/jimmunol.1402027 Parrot-Lopez, 2010, [Amphiphilic cyclodextrins and their applications:Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications], Ann. Pharm. Fr., 68, 12, 10.1016/j.pharma.2009.12.002 Parrotlopez, 1992, Self-Assembling systems of the amphiphilic cationic per-6-amino-beta-cyclodextrin 2,3-Di-O-Alkyl ethers, J. Am. Chem. Soc., 114, 5479, 10.1021/ja00039a100 Perez-Herrero, 2015, Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy, Eur. J. Pharmaceutics Biopharmaceutics, 93, 52, 10.1016/j.ejpb.2015.03.018 Quaglia, 2009, The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs, Biomaterials, 30, 374, 10.1016/j.biomaterials.2008.09.035 Quintanar-Guerrero, 1998, Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique, Pharm. Res., 15, 1056, 10.1023/A:1011934328471 Ragelle, 2016, Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures, Expert Opin. Drug Deliv., 1 Resnik, 2015, Highly selective anti-Cancer activity of cholesterol-interacting agents methyl-beta-Cyclodextrin and ostreolysin A/Pleurotolysin B protein complex on urothelial cancer cells, PLoS One, 10, e0137878, 10.1371/journal.pone.0137878 Roux, 2007, Self-assemblies of amphiphilic cyclodextrins, Eur. Biophys. J.: EBJ, 36, 861, 10.1007/s00249-007-0207-6 Saenger, 1998, Structures of the common cyclodextrins and their larger analogues – Beyond the doughnut, Chem. Rev., 98, 1787, 10.1021/cr9700181 Sallas, 2008, Amphiphilic cyclodextrins – advances in synthesis and supramolecular chemistry, Eur. J. Org. Chem., 957, 10.1002/ejoc.200700933 Salustio, 2011, Advanced technologies for oral controlled release: cyclodextrins for oral controlled release, AAPS PharmSciTech, 12, 1276, 10.1208/s12249-011-9690-2 Schardinger, 1903, Uber die Zulässigkeit des Warmhaltens von zum Gebuß bestimmten Nahrungsmittel mittelst Wärme speichernder Apparate, sog. Thermophore, Wien.K lin Wochenschr., 468 Schardinger, 1903, Über Thermophile Bakterien aus verschiedenen Speisen und Milch, sowie uber einige Umsetzungsprodukte derselben in kohlenhydrathaltigen Nahrlosungen, darunter krystallisierte Polysaccharide (Dextrine) aus Starke, Z. Untersuch. Nahr. u. Genussm., 6, 865, 10.1007/BF02067497 Schardinger, 1911, Bildung kristallisierter Polysaccharide (Dextrine) aus Stärkekleister durch Microben:Zentralbl, Bakteriol. Parasitenk. Abt. II, 29, 188 Sinha, 2002, Cyclodextrins as sustained-release carriers, Pharm. Technol., 44, 36 Skiba, 1995, Evaluation of gastrointestinal behaviour in the rat of amphiphilic β-cyclodextrin nanocapsules, loaded with indomethacin, Int. J. Pharm, 126, 275, 10.1016/0378-5173(95)04121-4 Soares, 2007, Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems, Nanomed.: Nanotechnol. Biol. Med., 2, 183, 10.2217/17435889.2.2.183 Sukegawa, 2002, Erythrocyte-like liposomes prepared by means of amphiphilic cyclodextrin sulfates, Chem. Commun., 430, 10.1039/b110673b Szejtli, 1998, Introduction and general overview of cyclodextrin chemistry, Chem. Rev., 98, 1743, 10.1021/cr970022c Szente, 1999, Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development, Adv. Drug Deliv. Rev., 36, 17, 10.1016/S0169-409X(98)00092-1 Todor, 2012, The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells, Exp. Oncol., 34, 97 Uekama, 1998, Cyclodextrin drug carrier systems, Chem. Rev., 98, 2045, 10.1021/cr970025p Uekama, 2004, Design and evaluation of cyclodextrin-based drug formulation, Chem. Pharm. Bull., 52, 900, 10.1248/cpb.52.900 Unal, 2015, Core-shell hybrid nanocapsules for oral delivery of camptothecin: formulation development, in vitro and in vivo evaluation, J. Nanopart. Res., 17, 10.1007/s11051-014-2838-8 Unal, 2015, Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin, Beilstein J. Org. Chem., 11, 204, 10.3762/bjoc.11.22 Varan, 2016, Cholesterol-Targeted anticancer and apoptotic effects of anionic and polycationic amphiphilic cyclodextrin nanoparticles, J. Pharm. Sci., 105, 3172, 10.1016/j.xphs.2016.06.021 Villiers, 1891, Sur la fermetation de la fécule de pommes par l’action du ferment butyrique, Comptes Rendus de l'Académie des Sciences, 112, 536 Weber, 2013, Cholesterol dependent uptake and interaction of doxorubicin in mcf-7 breast cancer cells, Int. J. Mol. Sci., 14, 8358, 10.3390/ijms14048358 Weiss, 2013, First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies, Invest. New Drugs, 31, 986, 10.1007/s10637-012-9921-8 Xu, 2015, Unimolecular micelles of amphiphilic cyclodextrin-core star-like block copolymers for anticancer drug delivery, Chem. Commun. (Camb), 51, 15768, 10.1039/C5CC02743H Xu, 2016, Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines, J. Control. Release, 225, 252, 10.1016/j.jconrel.2016.01.043 Yameogo, 2014, Progress in developing amphiphilic cyclodextrin-based nanodevices for drug delivery, Curr. Top. Med. Chem., 14, 526, 10.2174/1568026613666131219125135 Ye, 2016, Tumour-Targeted drug delivery with mannose-functionalized nanoparticles self-Assembled from amphiphilic beta-Cyclodextrins, Chem.–Eur. J., 22, 15216, 10.1002/chem.201603294 Zhang, 2013, Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective, Adv. Drug Deliv. Rev., 65, 1215, 10.1016/j.addr.2013.05.001 Zhang, 2016, Effect of cholesterol on cellular uptake of cancer drugs pirarubicin and ellipticine, J. Phys. Chemi. B, 120, 3148, 10.1021/acs.jpcb.5b12337 de Meyer, 2009, Effect of cholesterol on the structure of a phospholipid bilayer, Proc. Natl. Acad. Sci. U. S. A., 106, 3654, 10.1073/pnas.0809959106